|
| Exchange Disseminated Time | Himadri Chemicals & Industries Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company will be held on September 28, 2011, inter alia, at "Kala-Kunj Hall" 48, Shakespeare Sarani, Kolkata - 700 017 at 10.00 a.m., inter alia, to transact the following business;
1. To receive, consider and adopt the audited Balance Sheet as at March 31, 2011 and the Profit & Loss Account for the year ended on that date, together with the report of the Board of Directors and Auditors thereon.
2. To declare dividend.
3. To appoint a Director in place of Mr. Bankey Lal Choudhary, who retires by rotation and being eligible offers himself for re appointment.
4. To appoint a Director in place of Mr. Sakti Kumar Banerjee, who retires by rotation and being eligible offers himself for re appointment.
5. To appoint auditor and fix their remuneration.
6. Re-appointment of Mr. Bankey Lal Choudhary, as Managing Director of the Company for a further period of 2 (two ) years with effect from April 01, 2011, on remuneration, terms & conditions.
7. To create, offer and grant from time to time, up to 1,15,71,978 stock options in the aggregate to eligible employees, including any Director of the Company, whether whole time or otherwise, under the HCIL Employee Stock Option Scheme 2011 hereinafter referred as the "ESOS 2011"; each option would be exercisable for one Equity share of face value of Re. 1 each fully paid-up on payment of the requisite exercise price to the Company in one or more tranches, and on such terms and conditions as may be fixed or determined by the provisions of the law or guidelines issued by the relevant authorities.
8. To create, offer and grant from time to time, up to 77,14,650 stock options in the aggregate to eligible employees, including any Director whether whole time or otherwise of all the existing and future subsidiaries of the Company, under the HCIL Employee Stock Option Scheme 2011 hereinafter referred as the "ESOS 2011"; each option would be exercisable for one Equity share of a face value of Re. 1 each fully paid-up on payment of the requisite exercise price to the Company in one or more tranches, and on such terms and conditions as may be fixed or determined by the Board in accordance with the provisions of the law or guidelines issued by the relevant authorities. |
|
|